Skip to main content

Table 2 Health-related quality of life at 6 months of follow-up

From: Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: the NORDLAND study, a randomized trial

EQ-5D Utilities

Month 0

Month 1

Month 6

TM

n (%)

HM

n (%)

Total

n (%)

p

TM

n (%)

HM

n (%)

Total

n (%)

p

TM

n (%)

HM

n (%)

Total

n (%)

p

Mobility

No problems

15 (60.0)

12 (48.0)

27 (54.0)

0.29

16 (64.0)

14 (58.3)

30 (61.2)

0.46

17 (68.0)

16 (66.7)

33 (67.3)

0.58

Some problems

10 (40.0)

13 (52.0)

23 (46.0)

9 (36.0)

10 (41.7)

19 (38.8)

8 (32.0)

8 (33.3)

16 (32.7)

Extreme problems

0 (0.0)

0 (0.0)

0 (0.0)

0 (.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0)

0 (0.0)

Self-care

No problems

22 (88.0)

22 (88.0)

44 (88.0)

0.67

23 (92.0)

22 (91.7)

45 (91.8)

0.68

21 (84.0)

23 (95.8)

44 (89.8)

0.19

Some problems

22 (88.0)

22 (88.0)

6 (12.0)

2 (8.0)

2 (8.3)

4 (8.2)

4 (16.0)

1 (4.2)

5 (10.2)

Extreme problems

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Usual activities

No problems

16 (64.0)

14 (56.0)

30 (60.0)

0.84

13 (52.0)

13 (54.2)

26 (53.1)

0.55

18 (72.0)

12 (50.0)

30 (61.2)

0.22

Some problems

8 (32.0)

10 (40.0)

18 (36.0)

12 (48.0)

11 (45.8)

23 (46.9)

7 (28.0)

11 (45.8)

18 (36.7)

Extreme problems

1 (4.0)

1 (4.0)

2 (4.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (4.2)

1 (2.0)

Pain / discomfort

No problems

11 (44.0)

14 (56.0)

25(50.0)

0.08

13 (52.0)

15 (62.5)

28 (57.1)

0.71

13 (52.0)

12 (50.0)

25 (51.0)

0.87

Some problems

14 (56.0)

8 (32.0)

22 (44.0)

10 (40.0)

8 (33.3)

18 (36.7)

9 (36.0)

10 (41.7)

19 (38.8)

Extreme problems

0 (0.0)

3 (12.0)

3 (6.0)

2 (8.0)

1 (2.0)

3 (6.1)

3 (12.0)

2 (8.3)

5 (10.2)

Anxiety / depression

No problems

16 (64.0)

16 (64.0)

32 (64.0)

0.62

18 (72.0)

19 (79.2)

37 (75.5)

0.58

16 (64.0)

19 (79.2)

35 (71.4)

0.50

Some problems

9 (36.0)

9 (36.0)

18 (36.0)

6 (24.0)

5 (20.8)

11 (22.4)

7 (28.0)

4 (16.7)

11 (22.4)

Extreme problems

0 (0.0)

0 (0.0)

0 (0.0)

1 (4.0)

0 (0.0)

1 (2.0)

2 (8.0)

1 (4.2)

3 (6.1)

 

TOTAL [95CI]

0.81 [0.74;0.87]

0.76 [0.64;0.88]

0.78 [0.72;0.85]

0.47

0.79 [0.70;0.88]

0.83 [0.74;0.92]

0.81 [0.75;0.87]

0.49

0.82 [0.69;0.93]

0.76 [0.65;0.87]

0.79 [0.71;0.86]

0.54

EQ-5D VAS

 

TOTAL [95CI]

64.00 [55.77;72.23]

64.88 [51.69;74.07]

64.83 [56.74;70.14]

0.86

69.38 [60.82;76.38]

66.96 [59.17;74.75]

67.80 [62.49;73.10]

0.71

72.71 [65.58;79.83]

59.79 [49.44;70.14]

66.74 [60.46;73.01]

0.08

  1. TM tele-monitoring group, HM hospital monitoring group; N (month 0) = 50 (TM group: 25; HM group: 25). N (month 1) =49 (TM group: 25; HM group: 24). N (month 6) =49 (TM group: 25; HM group: 24). Values are expressed as means [95CI: 95% confidence interval of means]. EQ5D: EuroQoL-5D; VAS: Visual Analog Scale